In Alzheimer disease (AD), the perturbation of the endoplasmic reticulum (ER) calcium (Ca 2ϩ ) homeostasis has been linked to presenilins, the catalytic core in ␥-secretase complexes cleaving the amyloid precursor protein (APP), thereby generating amyloid-␤ (A␤) peptides. Here we investigate whether APP contributes to ER Ca 2ϩ homeostasis and whether ER Ca 2ϩ could in turn influence A␤ production. We show that overexpression of wild-type human APP (APP 695 ), or APP harboring the Swedish double mutation (APP swe ) triggers increased ryanodine receptor (RyR) expression and enhances RyR-mediated ER Ca 2ϩ release in SH-SY5Y neuroblastoma cells and in APP swe -expressing (Tg2576) mice. Interestingly, dantrolene-induced lowering of RyR-mediated Ca 2ϩ release leads to the reduction of both intracellular and extracellular A␤ load in neuroblastoma cells as well as in primary cultured neurons derived from Tg2576 mice. This A␤ reduction can be accounted for by decreased Thr-668-dependent APP phosphorylation and ␤-and ␥-secretases activities. Importantly, dantrolene diminishes A␤ load, reduces A␤-related histological lesions, and slows down learning and memory deficits in Tg2576 mice. Overall, our data document a key role of RyR in A␤ production and learning and memory performances, and delineate RyR-mediated control of Ca 2ϩ homeostasis as a physiological paradigm that could be targeted for innovative therapeutic approaches.
Introduction
Alzheimer's disease (AD) is the most common neurodegenerative disorder leading to dementia. Extracellular senile plaques, intracellular neurofibrillary tangles, and neuronal loss represent the main histological hallmarks of AD. Amyloid-␤ (A␤) peptides, the main components of senile plaques, result from the sequential endoproteolytic cleavage of amyloid precursor protein (APP) by ␤-secretase (BACE-1) and the presenilin (PS)-dependent ␥-secretase complex (Checler, 1995) . An increased level of A␤ is considered a key event contributing to AD etiology. As a support of the amyloid cascade hypothesis, most of the mutations in APP and PS1/PS2 responsible for early-onset familial AD (FAD) modulate A␤ production (Bekris et al., 2010) .
Calcium (Ca 2ϩ ) is one of the most important and versatile second messengers in cell signaling. In the nervous system, Ca 2ϩ ions play crucial roles in neurotransmitter synthesis and release, signal transmission, dendrite growth, spine formation, regulation of gene expression, as well as in synaptic plasticity (Berridge et al., 2003) . The ability of neurons to regulate the influx, efflux, and subcellular compartmentalization of Ca 2ϩ appears compromised in AD (Bezprozvanny and Mattson, 2008) . Importantly, one of the main changes observed in AD is a rise in the amount of Ca 2ϩ being released from the endoplasmic reticulum (ER) stores. A␤ enhances Ca 2ϩ release from the ER through both the inositol 1,4,5-triphosphate receptor (IP 3 R) and the ryanodine receptors (RyR) (Ferreiro et al., 2004) . FAD-linked PS1 and PS2 mutations trigger abnormal ER Ca 2ϩ homeostasis by potentiating IP 3 -and RyR-evoked Ca 2ϩ liberation, and decreasing ER Ca 2ϩ uptake (Leissring et al., 1999; Stutzmann et al., 2004 Stutzmann et al., , 2006 Cheung et al., 2008; Green et al., 2008; Brunello et al., 2009) . However, the role of PS in ER Ca 2ϩ leakage is debated (Tu et al., 2006; Shilling et al., 2012) .
Conversely, it was also reported that Ca 2ϩ homeostasis may influence APP pathophysiological processing. Therefore, A␤ production is enhanced by elevation of intracellular [Ca 2ϩ ] (Buxbaum et al., 1994; Querfurth and Selkoe, 1994) or increased RyR-mediated Ca 2ϩ release (Querfurth et al., 1997) , and is reduced in IP 3 R-deficient lines (Cheung et al., 2008) .
While perturbations of Ca 2ϩ homeostasis have been largely described in PS models, fewer studies have focused on the direct impact of APP on Ca 2ϩ homeostasis (Leissring et al., 2002; Lopez et al., 2008; Rojas et al., 2008; Niu et al., 2009) . Nevertheless, the characterization of subcellular Ca 2ϩ signaling dysregulation in APP-expressing models and the possible implication of RyR in APP-mediated Ca 2ϩ alteration have not been reported before. In addition, the blockade of RyR as a mean to modulate APP metabolism and A␤ production has not been investigated.
We provide here evidence that enhanced RyR-mediated Ca 2ϩ release occurs in the SH-SY5Y neuroblastoma cell line stably overexpressing either wild-type (WT) human APP (APP 695 ) or APP harboring the Swedish double mutation (K670N/M671L; APP swe ), and in primary neurons from APP swe -expressing mice (Tg2576). Interestingly, blockade of RyR-mediated Ca 2ϩ release by dantrolene reduces A␤ production in vitro, in both the SH-SY5Y model and Tg2576 primary neurons. Moreover, dantrolene diminishes A␤ load, reduces A␤-related histological lesions, and slows down learning and memory deficits in Tg2576 mice. Together, our data demonstrate that ER Ca 2ϩ dysregulation acts as an amplification pathway in the A␤ cascade and identify RyR as a target of Ca 2ϩ pathology linked to AD.
Materials and Methods
Chemicals. Dantrolene, SB415286 (3-[(3-Chloro-4-hydroxyphenyl) amino]-4-(2-nitrophenyl)-1H-pyrrole-2,5-dione), roscovitine (1,9-Pyrazoloanthrone, Anthrapyrazolone), SP600125, caffeine, and carbamoylcholine chloride were purchased from Sigma Aldrich. Antibodies. A␤, C99, and total APP were detected using the 6E10 antibody (Covance) recognizing residues 1-16 of A␤. A␤ was also detected using FCA18 antibody, recognizing free Asp1 residue of A␤1-x peptides (Barelli et al., 1997) . Total APP was detected using APP N-terminal antibody (22C11; Millipore) recognizing residues 66 -81 of APP, or APP C-terminal antibody (Sigma Aldrich) recognizing residues 676 -695 of APP. Phosphorylated APP (P-APP) was detected using P-APP antibody (Thr-668) (Cell Signaling Technology). Other antibodies directed toward the following proteins were as follows: GADPH (glyceraldehyde-3-phosphate dehydrogenase; Millipore); PSD-95, sarco/endoplasmic reticulum Ca 2ϩ -ATPase 2B (SERCA2B), Aph1, RyR1, RyR2, and RyR3 (Pierce); ␤-actin, IP 3 R1, IP 3 R2, and IP 3 R3 (Santa Cruz Biotechnology); BACE-1 and CytP450 (Abcam); SNAP-25 (Covance); Vamp-2 (Synaptic Systems); synapsin I and II and synaptotagmin (Stg; developed by F.B.); nicastrin (Sigma Aldrich); and PS1 (a generous gift from G. Thinakaran, University of Chicago, Chicago, IL).
Cell culture and infection. Human SH-SY5Y neuroblastoma cells (CRL-2266; American Type Culture Collection, Manassas, VA) were cultured following manufacturer's instructions. SH-SY5Y cells stably expressing pcDNA3.1, APP swe , or APP 695 constructs were generated following standard protocols and maintained in the presence of 400 g geneticin (Gibco).
For subcellular Ca 2ϩ analyses, 150,000 cells were spotted on 13 mm coverslips and placed 24 h later in contact with the appropriate adenoviral system expressing cytosolic (AdCMVcytAEQ)-or ER (AdCMVerAEQ)-targeted aequorin (AEQ) probes as described previously (Chami et al., 2008) .
Cell treatments and immunoblotting. APP swe -and APP 695 -expressing SH-SY5Y cells and primary cultured neurons were treated over night (20 h) with, respectively, 50 or 1 M dantrolene or vehicle (DMSO). Protein extracts were prepared using lysis buffer (50 mM Tris, pH 8, 10% glycerol, 200 mM NaCl, 0.5% Nonidet P-40, and 0.1 mM EDTA) supplemented with Complete protease inhibitors (Roche Diagnostics).
To detect A␤ peptide, 40 g of the total proteins were incubated with 70% formic acid (Sigma) and Speed Vac evaporated for 40 min. The pellets were dissolved in 1 M Tris, pH 10.8, and 25 mM betaine and diluted in 2ϫ Tris-tricine loading buffer (125 mM Tris-HCl, pH 8.45, 2% SDS, 20% glycerol, 0.001% bromophenol blue, and 5% ␤-mercaptoethanol). Proteins were resolved by 16.5% Tris-tricine SDS-PAGE, transferred onto nitrocellulose membranes, and incubated overnight with specific antibodies as specified in figure legends. All the other proteins were detected on total extracts resolved by SDS-PAGE following standard procedures.
Microsomal fraction preparation. Cells were harvested by trypsinization and centrifuged at 600 ϫ g for 10 min at 4°C. The pellets were resuspended in 1 ml isolation buffer [250 mM D-mannitol, 5 mM HEPES, pH 7.4, 0.5 mM EGTA, and 0.1% bovine serum albumin (BSA)] supplemented with protease inhibitor mixture. After chilling on ice for 20 min with frequent tapping, cells were disrupted by at least 200 strokes of a glass Dounce homogenizer, and the homogenate was centrifuged at 1500 ϫ g at 4°C to remove unbroken cells and nuclei. The supernatant was centrifuged at 100,000 ϫ g at 4°C for 1 h. The pellet containing the microsomal fraction was suspended in 0.25 M sucrose, and 10 mM TrisHCl, pH 7.4, supplemented with protease inhibitors.
Detection of extracellular A␤. Culture medium without serum was supplemented with protease inhibitors, 1 mM PMSF, and 0.1% BSA. After a brief centrifugation, supernatants were mixed with equal volumes of 20% trichloroacetic acid (TCA), incubated at 4°C for 30 min, and then centrifuged at 18,000 ϫ g for 15 min at 4°C. Pellets were washed with ice-cold acetone, centrifuged at 10,000 ϫ g for 5 min at 4°C, and then dried and dissolved with RIPA buffer (50 mM Tris-HCl, pH 8, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and 0.1% SDS) supplemented with protease inhibitors. A␤ content was assessed by 10 -20% Tris-tricine SDS-PAGE (Invitrogen).
The concentrations of A␤ 40 and A␤ 42 were measured in the culture medium by using the respective ELISA kits (Invitrogen) following the manufacturer's instructions.
Calcium measurements. CytAEQ was reconstituted with 5 M coelenterazine for 2 h in Krebs-Ringer modified buffer (KRB) containing the following (in mM): 125 NaCl, 5 KCl, 1 Na 3 PO 4 , 1 MgSO 4 , 5.5 glucose, and 20 HEPES, pH 7.4, supplemented with 1 mM CaCl 2 at 37°C. Cytosolic Ca 2ϩ signals were obtained upon application of 500 M carbamoylcholine chloride, 135 mM KCl, or 30 mM caffeine.
For reconstitution with high efficiency of the erAEQ, the luminal [Ca 2ϩ ] of this compartment was first reduced by incubating cells for 1 h at 4°C in KRB supplemented with 5 M n-coelenterazine, 1 M ionomycin, and 600 M EGTA. After this incubation, cells were washed extensively with KRB supplemented with 2% BSA before the luminescence measurement was initiated. The ER was refilled by exposing cells to 1 mM extracellular CaCl 2 . All aequorin measurements were performed in a purpose-built luminometer. The experiments were terminated by lysis of cells with 100 M digitonin in a hypotonic Ca 2ϩ -rich solution (10 mM CaCl 2 , H 2 O) to discharge the remaining aequorin pool. The light signal was collected and calibrated into [Ca 2ϩ ] values, as previously described (Chami et al., 2008) . After reaching the steady state value, cells were perfused with (50 M) 2,5-Di-(tert-butyl)-1,4-benzohydroquinone (tBuBHQ), thus blocking SERCA pump and activating passive ER Ca 2ϩ leakage.
Fura-2 AM Ca 2ϩ measurements were performed as described previously (Bisaillon et al., 2010) . Briefly, cells were loaded with 4 M fura-2 AM (Invitrogen). Cells were then washed and bathed in HEPES-buffered HBSS containing (in mM) 140 NaCl, 1.13 MgCl 2 , 4.7 KCl, 2 CaCl 2 , 10 D-glucose, and 10 HEPES, pH 7.4, for 10 min before Ca 2ϩ was measured. Fluorescence images of several cells were recorded and analyzed with a digital fluorescence imaging system (InCyt Im2; Intracellular Imaging). Fura-2 AM fluorescence was collected at 510 nm upon alternate excitation at 340 and 380 nm, and the ratio of fluorescence in response to 340 nm excitation to that in response to 380 nm excitation was obtained on a pixel-by-pixel basis and represented as raw data.
Whole-cell patch-clamp experiments. Standard whole-cell patch-clamp recordings were performed using an Axopatch 200B and Digidata 1440A (Molecular Devices) as described previously (Zhang et al., 2011) . Clampfit 10.1 software was used for data analysis. Pipettes were pulled from borosilicate glass capillaries (World Precision Instruments) with a P-97 flaming/brown micropipette puller (Sutter Instrument) and polished with DMF1000 (World Precision Instruments) to a resistance of 2-4 M⍀ when filled with pipette solutions containing the following (in mM): 145 Csmethanesulfonate, 20 Cs-1,2-bis-(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid (Cs-BAPTA), 8 MgCl 2 , and HEPES, pH adjusted to 7.2 with CsOH. Immediately before the experiments, cells were washed with bath solution containing the following (in mM): 110 TEA-Cl, 10 CsCl, 10 HEPES, and 10 CaCl 2 , pH was adjusted to 7.4 with CsOH. Only cells with tight seals (Ͼ16 G⍀) were selected for break in. Whole-cell currents were recorded every 2 s with a standard voltage ramp from Ϫ140 to 40 mV (lasting 180 ms) from a holding potential of Ϫ80 mV. Currents were low-pass filtered at 5 kHz and sampled at a rate of 10 kHz.
Neuronal cell cultures. Primary cultured neurons were obtained from individual e17 mice and then plated separately and genotyped for the presence of APP 695 transgene by PCR. Cortices and hippocampi were dissected and digested in 0.125% trypsin-HEPES-buffered saline solution for 30 min. Cells were seeded onto poly-L-lysine-coated tissue culture plates or glass coverslips. Cultures were incubated at 37°C, 5% CO 2 in Neurobasal medium (Invitrogen) supplemented with B-27. Medium was changed after 4 h with Neurobasal containing B-27 supplemented with 0.1% glutamine and 1% penicillin-streptomycin.
In vitro ␤-secretase assay. ␤-secretase activity was monitored using the ␤-secretase activity assay kit (Biovision). Briefly, 5,000,000 cells were lysed in ice-cold extraction buffer and centrifuged at 10,000 ϫ g for 5 min. The supernatant (50 g) was then incubated in the presence of BACE-1 substrate at 37°C in the presence or absence of 50 g BACE-1 inhibitor JMV2764 (Ac-RQIKIWFQNRRNle-KWKK-ahx-EVN-AHPPA-AEF-NH 2 ) (Buggia-Prevot et al., 2008) . BACE-1 activity corresponds to the JMV2764-sensitive fluorescence recorded at 320 nm (excitation) and 420 nm (emission) wavelengths.
In vitro ␥-secretase assay. In vitro ␥-secretase assay was assessed as described previously (Sevalle et al., 2009) . Intact cell pellets were suspended in 10 mM Tris, pH 7.5, supplemented with protease inhibitor mixture and subjected to repeated passages through a 25G needle. Homogenates were first centrifuged at 800 ϫ g for 10 min at 4°C, and the resulting supernatant was subjected to an additional 20,000 ϫ g centrifugation for 1 h at 4°C. Membrane-containing pellets were then resuspended in solubilization buffer [150 mM sodium citrate, pH 6.4, containing 3-[(3-cholamydopropyl) dimethylammonio]-2-hydroxy-1-propanesulfonate 1% (v/v)] supplemented with protease inhibitor mixture. All steps were performed at 4°C. Solubilized membranes (1 mg/ml) were diluted once with sodium citrate buffer (150 mM, pH 6.4) and with reaction buffer (150 mM sodium citrate, pH 6.4, 20 mM dithiothreitol, 0.2 mg/ml BSA, 1 mg/ml egg phosphatidyl choline, and 50 g/ml recombinant C100-Flag). The resulting reaction mix was then either incubated over constant agitation for 16 h at 37°C or stored at 4°C (negative controls). Samples were then supplemented with 2ϫ Tris-tricine loading buffer, boiled for 5 min, and subjected to Western blot for A␤ analysis using 16.5% Tris-tricine SDS-PAGE.
Quantitative real-time PCR. Total RNA was isolated using NucleoSpin RNA II (Macherey-Nagel) according to the manufacturer's protocol. Total RNA extraction form the cortex of WT and Tg2576 mice was isolated using RNAeasy lipid tissue (Qiagen) according to the manufacturer's protocol. cDNA was synthesized from 2 g of total RNA and random primers using the GoScript Reverse Transcription System kit (Promega). Target gene expression was analyzed by real-time PCR using Corbett Rotor-Gene 6000 (Invitrogen) and SYBR Green (Roche Applied Sciences). Cycling parameters were as follows: 20 s at 95°C, 20 s at 60°C, and 20 s at 72°C for 55 cycles. Primer sequences for human RyR isoforms were as follows: RyR1 forward, 5Ј-GCATGGCTTCGAGACTCAC-3Ј; RyR1 reverse, 5-ЈCATCTTCCAGAC ATAAGACTCCTG-3Ј; RyR2 forward, 5-'TGCTGGCTTGGGGCTGGAG-3Ј; RyR2 reverse, 5Ј-ACCATGGGCAGCGTCCACAG-3Ј; RyR3 forward, 5Ј-GACATGCGAGTCGGCTGGGC-3Ј; RyR3 reverse, 5Ј-GATGCCAACG CTGGCCCCTG-3Ј. Human ␤-Actin was used as control gene.
Primer sequences for mouse RyR isoforms were as follows: RyR1 forward, 5Ј-TCTTCCCTGCTGGAGACTGT-3Ј; RyR1 reverse, 5Ј-GTGGAGAAGG CACTTGAGG-3Ј; RyR2 forward, 5Ј-TCAAACCACGAACACATTGAGG-3Ј; RyR2 reverse, 5Ј-AGGCGGTAAAACATGATGTCAG-3Ј; RyR3 forward, 5Ј-CTGGCCATCATTCAAGGTCT-3Ј; RyR3 reverse, 5Ј-GTCTCCATGT CTTCCCGTA-3Ј. Mouse GAPDH was used as control gene. Hsiao et al. (1996) and carry human APP 695 cDNA with the Swedish double mutation at positions (K670M3 N671L) under the control of the hamster Prion promoter. The genotype of the mice was confirmed by PCR using DNA from tail tissues. Tg2576 mice and WT littermates of either sex between 12 and 15 months old were treated with 5 mg/kg dantrolene or with PBS (vehicle) by intraperitoneal injections twice a week during 3 months. All mice were weighed each month.
Dantrolene was freshly prepared in prewarmed PBS solution and subjected to brief sonication before injection. Dantrolene solution was mixed thoroughly before each injection. After 3 months of treatment, mice were subjected to behavioral testing and then killed. One half of the brains were immediately fixed in freshly depolymerized 4% paraformaldehyde and used for immunostaining. The other half of the brains were dissected to isolate cortices and hippocampi. Snap-frozen cortices were then homogenized to have a powder mixture that was used for protein and RNA isolation.
Immunohistochemical staining and quantification. Brains were sectioned to an 8 m thickness with a cryostat and stained for amyloid plaques. Slices were first washed with PBS and then incubated in formic acid for 6 min and then in H 2 O 2 for 15 min. Nonspecific sites were saturated in PBS, 0.05% Tween, and 5% BSA for 1 h. Slides were incubated overnight with primary antibodies (6E10, 1:1000 or FCA18, 1:500) prepared in PBS, Tween 0.025%. After washes, sections were incubated with secondary HRP-conjugated (1:1000; Jackson Laboratories) or Alexa 488-fluorescent antibodies (1:1000; Invitrogen) at room temperature for 1 h. Fluorescent slides were incubated for 5 min with DAPI (Roche; 1:20,000). Slides with HRP-conjugated antibodies were incubated with DAB-impact (Vector Laboratories), rinsed, and counterstained with cresyl violet. Images were captured using DM108 microscope (Leica) or an epifluorescence microscope (Axioplan2; Zeiss) under 10ϫ and 20ϫ magnification. Counting of A␤ plaques was performed on 15 serial slices from each animal blindly by two different researchers.
Morris water maze. The water maze test was performed in a 1.2-mdiameter pool. A 10-cm-diameter platform was placed in the southwestern quadrant in the hidden trials as described previously (Morris, 1984) . The procedure consisted of 5 d of hidden platform tests plus a probe trial 24 h after the last hidden platform test. In the hidden platform tests, mice were trained for four trials, with an intertrial interval of 10 min. After the probe test, mice were trained in a visible platform tests. In the visible platform test, mice were tested for four trials with an intertrial interval of 10 min. Tracking of animal movement was evaluated using an ANYmaze system (Ugo Basile).
Novel object recognition. Novel object recognition (NOR) was performed in a 44 ϫ 44 cm open-field chamber with opaque walls equipped with a digital video recording system as described previously (Bevins and Besheer, 2006) . The objects used during the task were object Legos different in shape and color. Mice were first habituated to the chamber for 10 min, during which ANY-maze (Ugo Basile) software quantified various locomotor parameters and anxiety-related behavior, including total distance traveled, time spent moving Ն50 mm/s, and number of entries into and time spent in the central part of open-field chamber.
Twenty-four hours after the habituation session, each mouse was subjected to training in a 10 min session of exposure to two different objects in the open-field box. The time spent exploring each object was recorded using video tracking. Exploration consisted of any investigative behavior (i.e., head orientation, sniffing occurring within Ͻ1.0 cm) or deliberate contact that occurred with each object. After the training session, the animal was returned to its home cage. After 24 h retention interval, the animal was returned to the arena with one familiar object and a novel one. Objects were counterbalanced between sessions and animals, and were cleaned with 70% ethanol after each trial. The time spent in exploring each object was then measured. A discrimination index was calculated as follows: object discrimination ϭ novel object explora-tion time/(familiar object exploration time ϩ novel object exploration time) ϫ 100. Animals that spent Ͻ20 s exploring the objects during the 10 min test session were omitted from the analysis.
Statistical analyses. Results are reported from at least three different experiments. Statistical analyses were done using t tests or one-way or two-way ANOVA. Bonferroni's, Dunnet's, or Tukey's multiple comparison post hoc analyses were subsequently performed on ANOVA results to determine significance.
Results

Cytosolic Ca
2؉ signaling is increased in APP swe -and APP 695 -expressing SH-SY5Y neuroblastoma cells We set up neuroblastoma SH-SY5Y cell lines stably overexpressing APP 695 or APP swe (Fig. 1A ). Both APP 695 -and APP swe -overexpressing cells yield increased levels of C99 (issued from cleavage by ␤-secretase; Fig. 1 A) and of A␤ 40 and A␤ 42 peptides [issued from sequential cleavages by ␤-and ␥-secretases; A␤ 42 (in pg/g of protein): 21.6 Ϯ 2.9, n ϭ 10 and 20.5 Ϯ 2.4, n ϭ 13 in APP swe -and APP 695 -expressing cells, respectively, vs 1.6 Ϯ 0.5, n ϭ 11 in mock-transfected cells; A␤ 40 (pg/g of protein): 229 Ϯ 46, n ϭ 5 and 160 Ϯ 27, n ϭ 9 in APP swe -and APP 695 -expressing cells, respectively, vs 17 Ϯ 3, n ϭ 6 in mock-transfected cells; Fig. 1 B] .
We analyzed Ca 2ϩ release from the ER by using a cytosolic Ca 2ϩ -based aequorin probe (Chami et al., 2008) . We first examined RyR-mediated Ca 2ϩ release upon cell stimulation with the RyR agonist caffeine (30 mM) (Riddoch et al., 2005) . As shown in Figure 1C , caffeine elicits a fast and large Ca 2ϩ transient that was amplified in APP swe -and APP 695 -expressing cells compared to control (peak, 1.96 Ϯ 0.05 M, n ϭ 24 and 2.09 Ϯ 0.04 M, n ϭ 22, respectively, vs 1.19 Ϯ 0.02 M, n ϭ 24 in control) (Fig. 1C) . We next investigated cytosolic Ca 2ϩ signal upon stimulation of Ca 2ϩ release through the IP 3 R. It was reported previously that the stimulation of SH-SY5Y cells with the muscarinic agonist carbamoylcholine chloride (carbachol) caused a cytosolic Ca 2ϩ response mainly mediated by Ca 2ϩ release from IP 3 -sensitive stores (van Acker et al., 2000) . Accordingly, carbachol (500 M) application triggers a transient increase in cytosolic Ca 2ϩ , the extent of which was significantly larger in APP swe -and APP 695 -expressing cells compared to control (peak, 4.63 Ϯ 0.07 M, n ϭ 24 and 4.30 Ϯ 0.05 M, n ϭ 24 respectively, vs 1.34 Ϯ 0.03 M, n ϭ 24 in control; Fig. 1 D) . Figure 1 E shows a significant increase in KCl-evoked Ca 2ϩ entry in APP swe -and APP 695 -expressing cells compared to control (peak, 1.51 Ϯ 0.05 M, n ϭ 23 and 1.57 Ϯ 0.08 M, n ϭ 24 respectively, vs 0.98 Ϯ 0.05, n ϭ 24 in control; Fig. 1 E) . VGCCmediated Ca 2ϩ entry may trigger Ca 2ϩ release from internal stores through a mechanism known as Ca 2ϩ -induced Ca 2ϩ release (CICR). To investigate CICR, we used dantrolene, a wellcharacterized antagonist of RyR channels (Muehlschlegel and Sims, 2009) , and measured Ca 2ϩ entry upon application of KCl (135 mM). Since APP 695 -and APP swe -expressing cells harbor the same alteration of Ca 2ϩ signals (Fig. 1C-E) , we performed these analyses on APP swe -expressing cells only. The results show that VGCC-mediated Ca 2ϩ entry is reduced upon dantrolene treatment in APP swe -expressing SH-SY5Y cells but not in pcDNA3.1-expressing cells (Fig. 1 F) . These data led us to conclude that RyR-mediated Ca 2ϩ signals contribute through the CICR mechanism to increased VGCC-mediated Ca 2ϩ entry in APP sweexpressing SH-SY5Y cells.
We also investigated Ca 2ϩ influx through voltageindependent plasma membrane Ca 2ϩ channels. Control and APP swe -expressing cells were incubated in EGTA-rich solution to buffer extracellular Ca 2ϩ followed by restoration of a Ca 2ϩ -rich solution to the extracellular milieu, thereby assessing basal Ca 2ϩ entry across the plasma membrane. We noticed that APP sweexpressing cells harbor increased basal [Ca 2ϩ ] illustrated by higher basal plateau values before the application of EGTA solution (F 340 /F 380 , 1.111 Ϯ 0.009, n ϭ 20 vs 1.075 Ϯ 0.008, n ϭ 20 in control) and larger Ca 2ϩ entry revealed by an increased plateau value reached upon addition of Ca 2ϩ -rich solution (F 340 /F 380 , 0.263 Ϯ 0.027, n ϭ 20 vs 0.170 Ϯ 0.020, n ϭ 20 in control; Fig. 1G ).
Together, these data reveal that APP overexpression determines an increase of cytosolic Ca 2ϩ signals due to combined increased Ca 2ϩ release from the ER through IP 3 R and RyR (Fig.  1C,D) , and enhanced Ca 2ϩ entry through voltage-dependent and voltage-independent plasma membrane Ca 2ϩ channels (Fig.  1 E, G) . Nevertheless, we show that elevated VGCC-mediated Ca 2ϩ signals in APP swe -expressing SH-SY5Y cells are a consequence of CICR through RyR (Fig. 1 F) .
The loading capacity of the ER is reduced in APP swe -and APP 695 -expressing SH-SY5Y neuroblastoma cells Increased Ca 2ϩ release from the ER through IP 3 R and RyR could be associated with altered ER Ca 2ϩ loading capacity. We investigated ER Ca 2ϩ content by using Ca 2ϩ -based aequorin probe targeted to the ER (Chami et al., 2008) . We measured the ER Ca 2ϩ load capacity upon application of 1 mM CaCl 2 -rich solution. As shown in Figure 2 A, ER Ca 2ϩ loading is reduced in APP swe -expressing cells compared to control (plateau, 166.0 Ϯ 3.7 M, n ϭ 15 vs 245.0 Ϯ 15.8 M, n ϭ 21 respectively; Fig. 2 A) . The analysis of ER Ca 2ϩ uptake capacity (ascending slope phase of the curve) did not reveal any difference between control and APP swe -expressing cells, thus ruling out a possible alteration of the activity of SERCA (uptake, 11.5 Ϯ 0.4 M/s, n ϭ 15 in APP sweexpressing cells vs 9.3 Ϯ 0.9 M/s, n ϭ 21 in control). We also analyzed the ER Ca 2ϩ passive leak upon SERCA inhibition by tBuBHQ. As displayed in Figure 2 B, APP swe -expressing cells show an increased Ca 2ϩ leakage from the ER compared to control cells (as revealed by increased slope, 0.85 Ϯ 0.03 M/s, n ϭ 15 in APP swe -expressing cells vs 0.51 Ϯ 0.02 M/s, n ϭ 21 in control) (Fig. 2 B) . These data demonstrate that the reduced Ca 2ϩ loading capacity in APP swe -expressing cells is due to increased Ca 2ϩ release through IP 3 R and RyR, and to elevated ER Ca 2ϩ passive leakage.
Increased Ca
2؉ entry in APP swe -expressing cells is not linked to altered function of store operated Ca 2؉ channels It is known that depletion of ER Ca 2ϩ activates Ca 2ϩ influx through the plasma membrane, a mechanism known as storeoperated Ca 2ϩ entry (SOCE) (Smyth et al., 2010) . We investigated SOCE in APP swe -expressing cells upon ER Ca 2ϩ depletion by carbachol-mediated IP 3 R Ca 2ϩ release, or by thapsigargin (TG)-mediated SERCA blockade in the presence of EGTA (Fig. 2C,D respectively) . Under these conditions, we confirm that Ca 2ϩ release from intracellular stores is larger in APP swe -expressing cells than in controls [carbachol peak (F 340 / F 380 ), 1.093 Ϯ 0.049, n ϭ 87 vs 0.409 Ϯ 0.096, n ϭ 83, respectively; TG peak (F 340 /F 380 ), 0.306 Ϯ 0.017, n ϭ 96 vs 0.212 Ϯ 0.029, n ϭ 97, respectively; Fig. 2C Since fura-2 measurements are prone to artifacts and a constitutive Ca 2ϩ entry under certain conditions could be amplified by the Ca 2ϩ off/Ca 2ϩ on protocol routinely used to assess SOCE, we also measured I CRAC (Ca 2ϩ release-activated Ca 2ϩ current), the main non-voltage-gated SOCE current, using standard electrophysiological recordings as described previously (Potier et al., 2009) . We show that passive store depletion by high concentrations (20 mM) of the fast chelator BAPTA activates an I CRAC current (sampled at Ϫ100 mV) with similar size and kinetics in APP swe -expressing cells and pcDNA3.1 control cells. Importantly, we notice that Gd 3ϩ -dependent I CRAC blockade occurs in a similar manner in pcDNA3.1-and APP swe -expressing cells (Fig.  2 E) . These data are further confirmed by representing the current-voltage ( I-V) relationships from the ramp protocol wherein current density was evaluated at various membrane potentials (Fig. 2 F) .
These experiments demonstrate that APP swe -expressing cells manifest a larger SOCE upon store depletion and did not reveal any alteration of I CRAC . Therefore, we postulate that increased Ca 2ϩ entry in APP swe -expressing cells is likely due to exaggerated unregulated basal Ca 2ϩ entry, and that this increase is not due to enhanced SOCE and I CRAC .
Altered ER Ca
2؉ homeostasis in APP swe and APP 695 SH-SY5Y cells is associated with increased expression of RyR The experiments in Figures 1 and 2 reveal that ER Ca 2ϩ homeostasis is largely deregulated in APP swe -expressing cells. Consequently, we focused our study on the molecular mechanisms underlying ER Ca 2ϩ store emptying. We analyzed the expression of Ca 2ϩ mobilizing proteins in this compartment, namely, RyR, IP 3 R, and SERCA2B. We noticed a higher expression of both IP 3 R and RyR in APP swe -and APP 695 -expressing cells (RyR, 2.2 Ϯ 0.4 and 1.8 Ϯ 0.5 fold increase, respectively, vs 0.8 Ϯ 0.1 in control; IP 3 R 2.0 Ϯ 0.2 and 1.9 Ϯ 0.3 fold increase, respectively, vs 1.0 Ϯ 0.1 in control; Fig. 3A ). As expected from Ca 2ϩ uptake experiments (Fig. 2 A) , no significant change in SERCA2B expression was observed in APP swe -and APP 695 -expressing cells (SERCA2B, 1.3 Ϯ 0.1 and 1.2 Ϯ 0.1 fold increase, respectively, vs 1.1 Ϯ 0.2 in control; Fig. 3A ). Since Tg2576 mice are characterized by a major accumulation of A␤ in the cortex, the same analyses were also performed on cortices isolated from 12-to 15-month-old Tg2576 mice and WT mice. Our data show that Tg2576 mice harbor an increased expression of RyR (1.5 Ϯ 0.1 fold increase in Tg2576 mice, n ϭ 4, vs 1.0 Ϯ 0.1, n ϭ 4, in WT mice), while the expression of IP 3 R is not significantly affected (Fig. 3B) .
Since, the induction of IP 3 R expression is observed only in SH-SY5Y model, and that the dysregulation of RyR expression is reported in both in vitro and in vivo APP-overexpressing models, we then compared mRNA expression levels of the three RyR isoforms in both SH-SY5Y model and Tg2576 mice. By using quantitative RT-PCR, we show an increased expression of RyR1, RyR2, and RyR3 mRNAs in APP swe -and APP 695 -expressing cells (RyR1, 1.5 Ϯ 0.11 and 1.7 Ϯ 0.03; RyR2, 1.6 Ϯ 0.14 and 1.7 Ϯ 0.13; RyR3, 1.52 Ϯ 0.12 and 1.64 Ϯ 0.13 fold increase in APP swe -and APP 695 -expressing cells, respectively, vs control cells taken as 1; Fig. 3C ). The same analyses performed on cortices isolated from 12-to 15-month-old Tg2576 and WT mice show a significant increase of the expression of RyR2 isoform, while the expression of RyR1 and RyR3 isoforms remain unchanged (RyR1, 0.69 Ϯ 0.26; RyR2, 1.45 Ϯ 0.17; RyR3, 0.72 Ϯ 0.30 fold increase in Tg2576 mice, vs WT mice taken as 1; Fig.  3D ). To note, comparative analyses of the expression (cycle threshold value which is defined as the number of cycles required for the fluorescent signal to exceed background level) of the three RyR isoforms reveal that in SH-SY5Y cells, RyR3 is more abundant than RYR2, which is more expressed than RyR1, while RyR2 and RyR3 are the major isoforms expressed in the cortex of Tg2576 and WT mice (data not shown).
Therefore, these data revel that RyR upregulation may underlie ER Ca 2ϩ homeostasis dysregulation in both the SH-SY5Y model and Tg2576 mice. (Querfurth et al., 1997) . Accordingly, treatment of APP swe -expressing cells with caffeine (5 mM) increases the production of C99 fragment derived from APP processing by ␤-secretase (Fig. 4A) .
We used dantrolene, to modulate RyRmediated Ca 2ϩ release (Muehlschlegel and Sims, 2009 ). The concentration and duration of treatment with dantrolene were determined in SH-SY5Y cells using cell viability test and Ca 2ϩ measurements analyses. Cell viability is not altered in APP sweexpressing SH-SY5Y cells treated for 20 h with dantrolene (50 M) (data not shown). Under these experimental conditions, we show that dantrolene significantly reduces RyR-dependent Ca 2ϩ release in APP sweexpressing cells, but not in control cells (Fig. 4B) .
We then assessed whether dantrolene could modify the proteolytic fragments derived from APP processing by ␤-secretase (C99) or ␤-and ␥-secretases (A␤ 40/42 ). Interestingly, dantrolene treatment reduces the production of C99 fragment in both APP swe -and APP 695 -expressing cells. Quantification revealed a reduction of C99 production of ϳ30% in APP swe -and APP 695 -expressing cells (Fig. 4C) . Dantrolene treatment also significantly decreases A␤ 42 production (A␤ 42 , 0.6 Ϯ 0.1 A.U., n ϭ 10 and 0.7 Ϯ 0.1 A.U., n ϭ 19 in dantrolene-treated APP 695 -and APP sweexpressing cells, respectively, vs vehicletreated cells taken as 1; Fig. 4D ).
Dantrolene decreases C99 and A␤ 42 production in APP swe primary cultured neurons To rule out any artifactual effect due to the immortalization of cell lines, we investigate the effect of dantrolene in primary cultured neurons isolated from WT and Tg2576 mice. Neurons from Tg2576 mice yield enhanced levels of C99 at 7 d in vitro (DIV) that is maintained at 12 and 15 DIV (Fig. 5A ). Tg2576 primary cultured neurons harbor an alteration of intracellular Ca 2ϩ signaling as demonstrated by the increased Ca 2ϩ release upon stimulation with caffeine (30 mM; peak, 5.57 Ϯ 1.05 M, n ϭ 7 and 3.29 Ϯ 0.32 M, n ϭ 8 in Tg2576 vs WT neurons respectively; Fig. 5B) , and an increased VGCC-dependent Ca 2ϩ entry upon stimulation with KCl (50 mM; peak, 2.70 Ϯ 0.25 M, n ϭ 13 and 1.83 Ϯ 0.17 M, n ϭ 13 in Tg2576 vs WT neurons respectively; Fig. 5C ).
In primary neurons, treatment with dantrolene (1 M; 20 h) does not alter cell viability (data not shown). Under these conditions, dantrolene reduces C99 peptide production (0.6 Ϯ 0.3 in dantrolene-treated Tg2576 neurons vs vehicle-treated Tg2576 neurons taken as 1; Fig. 5D ), and total A␤ peptide present in culture medium (54% Ϯ 13 in dantrolene-treated Tg2576 neurons vs vehicle-treated Tg2576 neurons taken as 100%; Fig. 5E ).
Data obtained in both SH-SY5Y-expressing cells and primary cultured neurons clearly demonstrate that the inhibition of RyRmediated Ca 2ϩ release controls APP processing and the production of C99 fragment and A␤ peptide.
Dantrolene-mediated reduction of C99 and A␤ production is associated with decreased ␤-and ␥-secretase activities and APP phosphorylation Amyloidogenic metabolism of APP implies its sequential cleavage by ␤-and ␥-secretases (Checler, 1995) . It was also reported that APP phosphorylation on Thr-668 (P-APP) plays a major role 695 -,andAPP swe -expressingcells.The graph represents the means Ϯ SEM of RyR, IP 3 R, and SERCA2B expression levels calculated versus CytP450 used as a loading control and presentedversusthepcDNA3.1expressionlevelvalue,takenas1.ThepvalueswerecalculatedversuspcDNA3.1usingone-wayANOVAand Dunnett's multiple comparison post hoc test. This result was obtained from at least three independent experiments. B, Western blot analyses of RyR and IP 3 R expression as revealed on total extracts isolated from cortices isolated from 12-to 15-month-old Tg2576 and WT mice. Each line corresponds to a different animal. The graph represents the means Ϯ SEM of RyR and IP 3 R expression levels calculated vs ␤-actin used as a loading control and presented versus WT expression level value, taken as 1. The p value was calculated versus WT mice using t test. The experiment was performed on four to five mice for each group. C, Relative RyR1, RyR2, and RyR3 mRNA expression in pcDNA3.1-, APP 695 -, and APP swe -expressing cells quantified versus ␤-actin mRNA. Graphs represent the means Ϯ SEM calculated versus pcDNA3.1-expressingcellstakenas1.ThepvalueswerecalculatedversuspcDNA3.1-expressingcellsusingone-wayANOVAandDunnett's multiple comparison post hoc test. This result was obtained from three independent experiments.D, Relative RyR1, RyR2, and RyR3 mRNA expression in cortices isolated from 12-to 15-month-old Tg2576 (n ϭ 7) and WT (n ϭ 8) mice quantified versus GAPDH mRNA. Graphs represent the means Ϯ SEM calculated versus WT mice, taken as 1. The p values were calculated versus WT mice using t tests. *p Ͻ 0.05; **p Ͻ 0.01; ***p Ͻ 0.001. ns, Nonsignificant.
in APP metabolism and the production of A␤ (Pierrot et al., 2006) . Therefore, the reduction of C99 and A␤ peptide production upon dantrolene treatment may be linked to decreased expression and/or activity of ␤-and ␥-secretases or alteration of APP phosphorylation on Thr-668.
We show that SH-SY5Y cells stably overexpressing APP swe or empty vector display similar expression levels of BACE-1 (␤-secretase) and PS1, Aph1, and nicastrin (components of the ␥-secretase complex) (Checler, 1995) , the expression levels of which remained unaffected by dantrolene (Fig. 6 A) .
We performed two sets of experiments in APP swe -expressing SH-SY5Y cells to investigate APP phosphorylation. First, we analyzed the extent of Thr-668 P-APP upon dantrolene treatment and used, as controls, inhibitors of candidate kinases thought to be implicated in APP phosphorylation (CdK5, GSK3␤, and JNK) (Muresan and Muresan, 2007) . As shown in Figure 6 B, the addition of dantrolene or CdK5, GSK3␤, and JNK kinase inhibitors (roscovitine, SB415286, and SP600125, respectively) significantly reduced the extent of Thr-668 P-APP (Fig. 6 B) . We then analyzed the time courses of APP phosphorylation and C99 production in dantrolene-treated APP swe cells and showed that dantrolene concomitantly and persistently reduces P-APP and C99 production level as soon as 1 h after treatment (Fig. 6C) . These data establish that dantrolene-like kinases inhibitors modulate APP phosphorylation on Thr-668 residue.
We then investigated the effect of dantrolene and of kinase inhibitors on in vitro ␤-and ␥-secretases activities. Our data show that ␤-secretase activity is significantly decreased upon treatment with dantrolene and roscovitine (48.0 Ϯ 8.5% and 61.2 Ϯ 16.6%, respectively, vs 100.0 Ϯ 10.8% in vehicle-treated cells, n ϭ 5; Fig.  6 D) , but not with SB415286 and SP600125 (92.0 Ϯ 23.0% and 79.5 Ϯ 23.3%, respectively, n ϭ 5; Fig. 6 D) .
We also monitored in vitro ␥-secretase activity in reconstituted membranes prepared from dantrolene-or kinase inhibitors-treated cells. We found that (1) the recombinant C100 fragment is cleaved at 37°C and to a much lesser extent at 4°C (negative control), and (2) A␤ production by membranes prepared from mock-or nontreated APP swe -transfected cells is similar. Interestingly, a significant reduction of A␤ production was observed with membranes prepared from dantrolene-treated APP swe -expressing cells compared to vehicle-treated ones (A␤ vs C100 signal, 0.65 Ϯ 0.07 vs 1.0 Ϯ 0.1 respectively; Fig. 6 E) . To rule out a putative direct effect of dantrolene on ␥-secretase that would have interfered with the in vitro assay, we incubated the C100 fragment with membranes isolated from untreated APP swe cells in the absence or the presence of dantrolene. Dantrolene does not modify the C100 fragment cleavage (data not shown), thus demonstrating that the reduction of ␥-secretase activity upon dantrolene treatment is not linked to a direct interaction of dantrolene with the ␥-secretase complex. Our data also reveal that kinase inhibitors reduce ␥-secretase activity in a significant manner with SB415286 (A␤ vs C100 signal, 0.52 Ϯ 0.09 vs 1.0 Ϯ 0.1 in vehicle-treated cells), and to a lesser extent with roscovitine and SP600125 (A␤ vs C100 signal, 0.73 Ϯ 0.09 and 0.64 Ϯ 0.08, respectively; Fig. 6 E) .
These data demonstrate that dantrolene reduces both ␤-and ␥-secretases activities and that under our experimental conditions, ␤-secretase activity is reduced upon Cdk5 inhibition, while ␥-secretase activity is reduced with GSK3␤ inhibition.
Dantrolene decreases A␤ production and the number of senile plaques in APP swe -expressing mice Our consistent data obtained in the SH-SY5Y cells and in primary neurons led us to explore the functional consequences of dantrolene in vivo. We used Tg2576 mice developed by Hsiao et al. (1996) . This model shows an impairment of learning and memory starting from 9 -10 months of age accompanied by an increase in A␤ 40 and A␤ 42-43 peptides and the development of mature senile plaques (Hsiao et al., 1996) . The chronic treatment (3 months) with dantrolene was administered to 12-to 15-month-old mice, i.e., when mice already displayed significant AD-related histological lesions and cognitive deficits. It is noteworthy that dantrolene has been used previously in vivo , and recent evidence suggests that it readily crosses the blood-brain barrier (for review, see Muehlschlegel and Sims, 2009) . Our data demonstrates that dantrolene treatment significantly reduces the density of A␤ plaques in Tg2576 mice (37 Ϯ 8 A␤ plaques per section, n ϭ 6 in dantrolene-treated Tg2576 mice vs 89 Ϯ 20 A␤ plaques per section, n ϭ 5 in vehicle-treated Tg2576 mice) as revealed using the 6E10 antibody recognizing 1-16 residues of A␤ peptides and C99 fragment (Fig. 7A) . A similar result was obtained using the FCA18 antibody that recognizes Asp 1 residue of A␤ 1-x peptides and C99 (Barelli et al., 1997) (Fig. 7A) . No staining was detected with these antibodies in WT mice. Dantrolene-treated Tg2576 mice also exhibit a lower production of C99 and total A␤ peptide than vehicle-treated mice (C99, 0.6 Ϯ 0.1; A␤, 0.4 Ϯ 0.1, n ϭ 13-18 in dantrolene-treated mice compared to vehicle-treated mice taken as 1, n ϭ 10 -13; Fig. 7B ).
Dantrolene prevents the loss of expression of PSD-95 and learning and memory deficits in Tg2576 mice
As dantrolene reduced A␤ burden in Tg2576 mice in vivo, we hypothesized that this may lead to prevention of AD-related phenotype in this model, i.e., alteration of synaptic function and learning and memory decline.
We analyzed the expression of presynaptic proteins implicated in vesicles mobilization and docking (synapsin I, SNAP-25, VAMP-2, and Stg), as well as of postsynaptic scaffold protein (PSD-95). PSD-95 expression is significantly reduced in 15-to 18-month-old Tg2576 mice compared to age-matched WT mice (0.6 Ϯ 0.1, n ϭ 10 vs 1.0 Ϯ 0.1, n ϭ 13 in Tg2576 and WT mice, respectively), while there is no significant modification of the expression of presynaptic SNAP-25, VAMP-2, Stg, and synapsin I proteins (Fig. 7C) . Consequently, we examined the impact of dantrolene on the expression of PSD-95 in WT and Tg2576 mice. Dantrolene abolishes the reduction of PSD-95 expression observed in Tg2576 mice (1.1 Ϯ 0.1, n ϭ 13 vs 0.5 Ϯ 0.1, n ϭ 10 in dantrolene-vs vehicle-treated mice, respectively; Fig. 7D ) and remains pharmacologically inert in WT mice (1.2 Ϯ 0.1, n ϭ 9, vs 1.0 Ϯ 0.1, n ϭ 13; Fig.  6D ). These data indicate that the restoration of normal PSD-95 levels by dantrolene parallels the reduction of the A␤ burden observed in dantrolene-treated Tg2576 mice.
It was reported previously that Tg2576 mice harbor learning and memory deficits (Hsiao et al., 1996) . We thus investigated the impact of dantrolene treatment on these two parameters by using two complementary tests: the Morris water maze (MWM) (Morris, 1984), which tests spatial learning memory, and the novel object recognition paradigm, which records recognition memory (Bevins and Besheer, 2006) . In the MWM, WT and Tg2576 mice treated with vehicle or dantrolene have similar escape latencies to find visible platform (Fig. 8 A) , thus indicating that motility and vision are not affected in Tg2576 mice and that dantrolene treatment does not affect these parameters. Both WT and Tg2576 mice are also able to learn the MWM task, as the average escape latency for each group gradually decrease to reach a predetermined criterion (Ͻ25 s average latency) during 5 d of hiddenplatform training trials. However, vehicle-treated Tg2576 mice show significantly lower learning performance since they reach criterion on day 5, while vehicle-treated WT mice reach it on day 4 (escape latency on day 4, 39.2 Ϯ 2.7 s, n ϭ 11 for vehicle-treated Tg2576 mice vs 24.6 Ϯ 2.2 s, n ϭ 8 for vehicle-treated WT mice; Fig. 8 B) . Analyses of the path length and of the path efficiency confirm these data (Path length on day 4, 5 Ϯ 0.5 m, n ϭ 11 for vehicle-treated Tg2576 mice vs 2.5 Ϯ 0.3 m, n ϭ 8 for vehicletreated WT mice; Fig. 8C ; path efficiency on day 4, 0.15 Ϯ 0.03 m, n ϭ 11 for vehicle-treated Tg2576 mice vs 0.29 Ϯ 0.03 m, n ϭ 8 for vehicle-treated WT mice; Fig. 8 D) . Importantly, dantrolene improves learning ability in Tg2576 mice compared to vehicletreated Tg2576 mice (escape latency on day 4, 21.5 Ϯ 4.3 s, n ϭ 10 vs 39.2 Ϯ 2.7 s, n ϭ 11, respectively; Fig. 8 B; path length, 2.3 Ϯ 0.4 m, n ϭ 10 vs 5.0 Ϯ 0.5 m, n ϭ 11, respectively; Fig. 8C ; path efficiency, 0.33 Ϯ 0.06 m, n ϭ 10 vs 0.15 Ϯ 0.03 m, n ϭ 11, respectively; Fig. 8 D) . Our data also reveal that dantrolene treatment does not affect learning ability in WT mice (Fig. 8 B-D) and restores learning ability in Tg2576 mice to a statistically similar level to that observed in WT mice ( p Ͼ 0.5). At the probe trial, no difference in the time spent in the target quadrant was found between dantrolene-treated Tg2576 mice and vehicle-treated Tg2576 mice (data not shown). Therefore, we also explored recognition memory using the NOR paradigm (Taglialatela et al., 2009) . In this test, mice were less exposed to stress conditions compared to the MWM test. During the setup of the NOR apparatus and training paradigm, we confirmed the absence of any artifactual preference for a specific object (color and form) between all groups of mice and verified that Tg2576 mice were not anxious and did not harbor motility decline (data not shown). The total object exploration time during training session was not different in dantrolene-and vehicle-treated WT and Tg2576 mice (data not shown). After 24 h retention, we performed a testing session where the sample objects were reintroduced, one being identical to the training object, i.e., the familiar object, and the other being a novel object. Total exploration time during the testing session is not significantly different between dantroleneand vehicle-treated WT and Tg2576 mice (data not shown). However, vehicle-treated Tg2576 mice show a clear reduction in the object discrimination ratio as compared to vehicle-and dantrolene treated WT mice (Discrimination index: 47.6 Ϯ 5.7, n ϭ 11 vs 66.6 Ϯ 4.9, n ϭ 11 and 55 Ϯ 6.3, n ϭ 6, respectively) (Fig.  8 E) . Importantly, dantrolene treatment increased the object discrimination index as compared to vehicle-treated Tg2576 mice (Discrimination index: 72.7 Ϯ 3.6, n ϭ 10 vs 47.6 Ϯ 5.7, n ϭ 11, respectively), thus reflecting an increase in the exploration time of the novel object vs the familiar object in dantrolene-treated Tg2576 mice (Fig. 8 E) . As for the MWM, in the NOR paradigm, we also revealed that dantrolene treatment restores the object discrimination index in Tg2576 mice to a statistically similar level to that observed in vehicle-treated WT mice (Discrimination index: 72.7 Ϯ 3.9, n ϭ 10 vs 66.6 Ϯ 4.9, n ϭ 11, respectively; p Ͼ 0.5). These results demonstrate that dantrolene reduces both learning and memory decline in Tg2576 mice. Together, our data demonstrate that the blockade of RyR-mediated Ca 2ϩ release by dantrolene simultaneously reduces A␤ load, prevents the loss of PSD-95 expression, and prevents learning and memory deficits in vivo.
Discussion
We report herein that WT or mutated APP overexpression triggers a large increase of cytosolic Ca 2ϩ signals mainly linked to increased ER Ca 2ϩ release and passive Ca 2ϩ leakage (Figs. 1, 2) . Importantly, we reveal the implication of RyR in APP-associated Ca 2ϩ alteration. Therefore, we show that RyR expression and RyR-mediated Ca 2ϩ release are enhanced in both in vitro and in vivo APP-overexpressing models. We also reveal the participation of CICR through RyR in Ca 2ϩ entry via VGCC in APP sweexpressing cells. Interestingly, the CICR-associated pathway was not observed in control cells, suggesting that the larger responses of VGCC in APP swe -expressing cells may arise principally from greater CICR through RyR. Exacerbated IP 3 R-evoked Ca 2ϩ signals observed in APP swe -expressing cells may also be due to increased CICR through the RyR. This phenomenon was reported in two other AD mice models (PS1 M146V and 3xTg-AD) (Stutzmann et al., 2006) .
It is known that depletion of ER Ca 2ϩ activates SOCE (Smyth et al., 2010) . However, our data reveal that increased Ca 2ϩ entry in APP swe -expressing cells cannot be accounted for by altered SOCE or I CRAC . We suggest that the elevated cytosolic [Ca 2ϩ ] observed in APP swe -expressing cells is contributed by alternative mechanisms, namely, (1) alteration of Ca 2ϩ extrusion by PMCA and Na ϩ /Ca 2ϩ exchanger (NCX), (2) activation of NCX in Ca 2ϩ influx/Na ϩ efflux mode, (3) reduction of the buffering capacity, or, as reported previously, (4) exaggeration of Ca 2ϩ entry through A␤ pore in the plasma membrane (Demuro et al., 2011) .
The kinetics of Ca 2ϩ slope after Ca 2ϩ responses are not altered in APP swe -expressing cells compared to control (Fig. 1C-E) , thus excluding an alteration of PMCA and NCX pumping function. We also did not see any evidence for a modification of Ca 2ϩ entry upon addition of methoxy]phenyl]ethyl ester, methanesulfonate (1:1), Carbamimidothioic acid), an inhibitor of NCX reverse mode (Magi et al., 2005) . This excludes the implication of NCX operating in Ca 2ϩ influx/Na ϩ efflux mode in the observed increased Ca 2ϩ entry (data not shown).
APP swe -expressing cells harbor an increased basal Ca 2ϩ level as revealed in Figure 1G . Accordingly, elevated resting [Ca 2ϩ ] was reported previously in APP swe -derived neurons (Lopez et al., 2007) , and reduced expression of the calcium binding protein calbidin-D28K was also described in AD (Riascos et al., 2011) . Moreover, it was demonstrated previously that A␤ oligomers aggregate into a Ca 2ϩ -permeable pore in the plasma membrane (Demuro et al., 2011) . It is therefore tempting to speculate that elevated Ca 2ϩ entry in APP swe -expressing cells may be a consequence of two mutually nonexclusive mechanisms: (1) a constitutive Ca 2ϩ entry through A␤ oligomers in the plasma membrane and/or (2) reduced buffering capacity.
Alteration of ER Ca 2ϩ homeostasis was reported in various AD models. Importantly, deviant RyR-mediated Ca 2ϩ release and enhanced RyR expression were described in 3xTg-AD-and PS1 M146V -expressing mice models (Chan et al., 2000; Smith et al., 2005; Stutzmann, 2007; Chakroborty et al., 2009) . It was proposed that PSs were the predominant Ca 2ϩ -deregulating factor in AD and that they may trigger RyR expression and activation in these models. Accordingly, it was demonstrated previously that PS1 and PS2 directly increase RyR single-channel activity through protein-protein interaction (Hayrapetyan et al., 2008; Rybalchenko et al., 2008) . We provide here evidence that enhanced RyR expression and RyR-mediated ER Ca 2ϩ release occurred in an AD-related model independently of PS mutation or overexpression. Thus, our data reinforce the implication of ER 
Ca
2ϩ homeostasis dysregulation in AD and point out RyR expression and/or function dysregulation as a common key player in AD "calciopathy."
Elevated RyR levels have been described early in human AD cases and in mild cognitive impairment (Kelliher et al., 1999; Bruno et al., 2011) . Accordingly, alterations of RyR expression and/or function were found to occur in 3xTg-AD mice model before A␤ formation, tau deposits, or memory deficits (Chakroborty et al., 2009) . These data suggest that dysregulation of RyR may represent an etiological trigger that may contribute to the setting of histopathological lesions and synaptic deficits that are associated with the later disease stages. Our study reveals that alterations of RyR-dependent Ca 2ϩ signals likely contribute to the progression of AD pathogenesis through the amplification of A␤ peptide production and memory decline. In these contexts, RyR emerges as a key factor that could be implicated in both initiation and progression of AD.
We show an induction of RyR1, RyR2, and RyR3 isoforms in APP 695 -and APP swe -expressing SH-SY5Y cells. Upregulation of the RyR2 isoform, but not of RyR1 and RyR3, was also observed in the cortex of Tg2576 mice. Similar results were reported in 3xTg-AD mice (Chakroborty et al., 2009 ). Therefore, we suggest that RyR2 upregulation may underlie the enhanced RyR-mediated Ca 2ϩ release in Tg2576-derived neurons. Since the induction of different RyR isoforms at the mRNA and protein levels was described in distinct AD models and at different stages of AD pathology, it appears of most interest to study the molecular pathway(s) underlying the control of RyR expression. In the context of APP-overexpressing models, we may speculate that RyR expression may be regulated by an APP-intracellular domain fragment, a transcriptively active modulator (Pardossi-Piquard and Checler, 2012) that has been described previously to modulate IP 3 -mediated Ca 2ϩ signaling (Leissring et al., 2002) .
Enhanced ER Ca 2ϩ emptying in APP swe models may also be linked to pathophysiological posttranslational modifications in the macromolecular complex containing RyR1 or RyR2 resulting in "leaky channels" (Marx et al., 2000; Bellinger et al., 2009; Gant et al., 2011) . Specific experiments are needed to demonstrate whether the increased ER passive Ca 2ϩ leakage observed in APP swe -expressing cells (Fig. 2 B) is associated to a dysfunction in the RyR macromolecular complex. It was initially demonstrated that RyR1 and RyR3 are the targets of dantrolene (Zhao et al., 2001 ). Interference of dantrolene with Figure 9 . Scheme of the potential mechanisms underlying the reduction of C99 and A␤ production upon dantrolene treatment in APP-overexpressing models. Dantrolene modulates RyR-mediated Ca 2ϩ release. This is associated with the reduction of APP phosphorylation on the Thr-668 residue likely through the control of the activity of Cdk5 and GSk3␤ kinases; in parallel, dantrolene also reduces ␤-and ␥-secretase activities. Cdk5 and GSK3␤ control the activity of ␤-and ␥-secretases, respectively. Therefore, dantrolene, Cdk5, and GSK3␤ modulate in concert both APP phosphorylation on Thr-668 and ␤-and ␥-secretase activities. This leads to the reduction of C99 and A␤ production in vitro and in vivo, preventing learning and memory decline in vivo linked to AD. The MWM test and the NOR paradigm were performed on 12-to 15-month-old WT and Tg2576 mice treated as in Figure 7 . A-D, The MWM test was performed as described in Materials and Methods. A, In the visible platform test, WT and Tg2576 mice treated with vehicle or dantrolene were tested the same day for four trials, with an intertrial interval of 10 min. The graph shows the average escape latency (in seconds) to find visible platform for each group in each trial. B-D, In hidden platform test, mice were trained also for four trials, with an intertrial interval of 10 min for 5 consecutive days. Graphs show the average of latency (in seconds; B), path length (in meters; C), and path efficiency (the ratio of shortest path length to actual path length; D) to escape to the hidden platform in all four groups of mice recorded each day. The p values were calculated using two-way ANOVA and Bonferroni's post hoc test. *p Ͻ 0.05, **p Ͻ 0.01, calculated in dantrolene-treated Tg2576 mice versus vehicle-treated Tg2576 mice.
# p Ͻ 0.05, calculated in vehicletreated Tg2576 mice versus vehicle-treated WT mice. The averages of latency (is seconds; B), path length (in meters; C), and path efficiency were not significant between vehicleand dantrolene-treated WT mice. E, The NOR paradigm was done in all four groups of mice as the MWM test. Twenty-four hours after the habituation session, mice were subjected to training in a 10 min session of exposure to one familiar object and to a novel object. The time spent in exploring each object was then measured, and a discrimination index was then calculated as described in Material and Methods. p values were calculated versus vehicle (Veh)-treated WT mice or vehicle-treated Tg2576 mice using one-way ANOVA and Tukey's post hoc test. *p Ͻ 0.05; **p Ͻ 0.01. n, Number of mice analyzed.
cardiac and neuronal RyR2 isoforms has been disputed, although it has recently been proposed to have effects on cardiac RyR2 (Jung et al., 2012; Maxwell et al., 2012) . Our findings demonstrate the potential use of dantrolene as a tool to modulate RyR-mediated Ca 2ϩ signals; however, other approaches must be considered such as modulators of the RyR macromolecular complex (Bellinger et al., 2009) .
It was reported previously that APP phosphorylation on Thr-668 residue is necessary for intraneuronal accumulation of A␤ (Lee et al., 2003; Pierrot et al., 2006; Muresan and Muresan, 2007) , and that the activity of Cdk5 and GSk3␤ kinases implicated in APP phosphorylation are calpain and Ca 2ϩ dependent (Nath et al., 2000; Lebel et al., 2009) .
It is possible to envision the following scenario ( Fig. 9) : dantrolene, through the modulation of RyR-mediated Ca 2ϩ release, reduces APP phosphorylation on Thr-668 residue, likely through the control of Cdk5 and GSk3␤ kinases activities; in parallel, dantrolene also reduces ␤-and ␥-secretases activities. This may occur directly since Ca 2ϩ interacts with ␤-and ␥-secretases to enhance their activities (Hayley et al., 2009; Ho et al., 2010) , or indirectly through the control of Cdk5 and GSK3␤ activities. Therefore, dantrolene modulates in concert both APP phosphorylation on Thr-668 and ␤-and ␥-secretase activities, leading to the reduction of C99 and A␤ production, likely preventing learning and memory decline (Fig. 9) .
We show herein that Tg2576 mice harbor a reduced level of PSD-95 [a component of the postsynaptic density membraneassociated guanylate kinase (PSD-MAGUK) scaffolding proteins]. In line with these results, reduced PSD-MAGUKs expression, i.e., PSD-95 and SAP-102 were also reported in autopsied AD brains (Proctor et al., 2010) . It is well established that PSD-MAGUK indirectly regulates synaptic plasticity and memory through the control of the number and compartmentalization of both AMPA and NMDA glutamate receptors around the PSD (Elias et al., 2008) . In addition, Goussakov et al. (2010) showed a profound RyR-mediated Ca 2ϩ increase within dendritic processes and spines and larger NMDA-evoked Ca 2ϩ signals in the 3xTg-AD strain. We hypothesize that excessive postsynaptic RyR-mediated Ca 2ϩ release and subsequent increased A␤ load may have contributed to PSD-95 expression decline in Tg2576 mice. This may have led directly or indirectly to learning and memory decline.
About 30 millions individuals are estimated to be affected with AD worldwide, and to date no effective treatment exists to arrest disease progression. Although therapeutic approaches targeting Ca 2ϩ influx have demonstrated efficacy in animal AD models, very few have been successful in clinical trials, namely, the L-type Ca 2ϩ channel blocker nimodipine (Tollefson, 1990) and the NMDA open receptor blocker memantine (Bullock, 2006) . Targeting of ER Ca 2ϩ homeostasis as a therapeutic approach for AD was not investigated before. Dantrolene was originally used for the treatment of malignant hyperthermia (Harrison, 1975) . However, recent in vitro and in vivo studies revealed the neuroprotective effect of dantrolene. Thus, dantrolene was shown to protect cells in vitro against the adverse consequences of the PS1 mutation (Guo et al., 1999) and to be neuroprotective in vivo in spinocerebellar ataxia types 2 and 3 and in Huntington's disease (Chen et al., 2008 Liu et al., 2009) .
We provide here evidence that dantrolene treatment reduces A␤ burden in vitro and in vivo and prevents the reduction of PSD-95 expression and learning and memory decline in vivo. Our study reveals RyR as a potential target for the treatment of AD and paves the way for the development of therapeutic strategies for AD based on modulating ERdependent Ca 2ϩ release mechanisms.
